The expression of HLA-DP in gastric cancer was lower, with only 21% of patients showing 50%–100% expression of HLA-DP on tumor cells and 66% of cases having almost no expression of HLA-DP on tumor cells (Figure 8, C and D). This evidence concerns the gene HLA-DPB1 and neoplasm.